Accelerated hypofractionated intensity modulated radiotherapy (IMRT) for early stage non-small cell lung cancer (NSCLC) in patients not suitable for conventional stereotactic ablative radiotherapy (SABR)

被引：0
|
作者：
Lavin, V. [1 ]
Whitehurst, P. [2 ]
Harris, C. [2 ]
Goldstraw, R. [2 ]
Bayman, N. [1 ]
Chan, C. [1 ]
Coote, J. [1 ]
Harris, M. [1 ]
Pemberton, L. [1 ]
Sheikh, H. [1 ]
Woolf, D. [1 ]
Faivre-Finn, C. [1 ]
机构：
[1] Christie Hosp NHS Fdn Trust, Clin Oncol, BX, Manchester, Lancs, England
[2] Christie Hosp NHS Fdn Trust, Med Phys, BX, Manchester, Lancs, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
118
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [1] Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)
    Islam, Mohammad
    Cyriac, Abby
    Durga, Tarun
    Sarkodie, Thomas
    Begum, Gulshad
    Evans, Joanne
    Palvai, Sreekanth
    Tun, Khin
    LUNG CANCER, 2023, 178 : S55 - S55
  • [2] CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)
    Leschenko, Y.
    Chebotareva, T.
    Spizhenko, N.
    Fedusenko, A.
    Sharaevskiy, O.
    Buryk, V.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S39 - S39
  • [3] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [4] HYPOFRACTIONATED RADIOTHERAPY WITH STEREOTACTIC LOCALIZATION IN EARLY STAGE NON-SMALL CELL LUNG CANCER (NSCLC)
    Salvi, F.
    Donini, E.
    Baldissera, A.
    Degli Esposti, C.
    Martelli, O.
    Monari, F.
    Spagnolli, F.
    Frezza, G.
    Palombarini, M.
    Romagnoli, R.
    LUNG CANCER, 2009, 64 : S48 - S49
  • [5] Is stereotactic ablative radiotherapy (SABR) clinically suitable in early stage non-small cell lung cancer (NSCLC) patients with WHO performance status (PS) 3?
    Hassani, A.
    Pickles, R.
    Mackenzie, L.
    McCallum, H.
    Turnbull, H.
    Atherton, P.
    Iqbal, M. S.
    LUNG CANCER, 2018, 115 : S58 - S58
  • [6] Immune Activation in Early Stage Non-Small Cell Lung Cancer (NSCLC) following Stereotactic Ablative Radiotherapy (SABR) and Surgery
    Aerts, Joachim G.
    De Goeje, Pauline
    Schram, Merel
    Bezemer, Koen
    Kaijen-Lambers, Margaretha
    Hegmans, Joost
    De langen, Joop
    Maat, Alexander
    Nuyttens, Joost
    Hendriks, Rudi
    Smit, Egbert
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S326 - S326
  • [7] Preliminary results of prospective data for patients receiving stereotactic ablative radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC)
    Pickles, R. L.
    Iqbal, S.
    Atherton, P.
    Turnbull, H.
    Mcmenemin, R.
    Walker, C.
    Pilling, K.
    Muller, M.
    Mott, J.
    Mccallum, H.
    LUNG CANCER, 2016, 91 : S47 - S48
  • [8] STEREOTACTIC ABLATIVE RADIOTHERAPY OF EARLY STAGE NON-SMALL CELL LUNG CANCER
    Cvek, Jakub
    Feltl, David
    Knybel, Lukas
    Otahal, Bretislav
    Skacelikova, Eva
    Binarova, Andrea
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S537 - S537
  • [9] Stereotactic Ablative Radiotherapy (SABR) in Potentially Operable Patients with Stage I Non-small Cell Lung Cancer
    Lagerwaard, F. J.
    Verstegen, N. E.
    Haasbeek, C. J. A.
    Slotman, B. J.
    Smit, E. F.
    Paul, M. A.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S79 - S80
  • [10] STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN POTENTIALLY OPERABLE STAGE I NON-SMALL CELL LUNG CANCER PATIENTS
    Lagerwaard, Frank J.
    Verstegen, Naomi E.
    Haasbeek, Cornelis J.
    Slotman, Ben
    Paul, M. A.
    Smit, Egbert F.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S278 - S279
12345